Episode 1 of Supply Chain Signal breaks down the FDA's PreCheck pilot, the US Section 301 probe into German drug pricing, and CMS's move to make Medicare drug price negotiation permanent. The debut ...
Brent Wilhelm of Cencora discusses why available inventory still leads to shortages, and how tighter distributor-manufacturer integration and AI could close the gap. In part 1 of a 3-part interview ...
PwC's Roel van den Akker says pharma M&A ran beyond expectations in the first half of 2026, with dealmaking potentially on pace to hit $300 billion in H2. Pharmaceutical Commerce recently checked in ...
In this week's Pharma Pulse, CVS Caremark settles with the FTC over rebates and TrumpRx, Germany more than doubles its drug rebate, and the FDA proposes a registration rule. Welcome to Pharma Pulse, a ...
Lilly will pay $6.75 per share (~26% premium), totaling $2.8 billion upfront with up to $1 billion milestone-based consideration, and expects closure in Q3 2026. Federal acceleration of psychedelic ...
Shawn Seamans, Chief Commercial Officer, CoverMyMeds | Authors | Pharmaceutical Commerce connects biopharma executives to insights on business processes, technologies, and strategies for taking ...
In this Dedicated Dialogue episode, Adam Fox, Chief Quality & Regulatory Affairs Officer of Cryoport Systems, explores how escalating regulatory expectations and patient-centric risk considerations ...
Embedding access tools at prescribing reduces manual enrollment, portal switching, and late activation, enabling faster ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results